Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.
Every year, the American Diabetes Association (ADA) issues Clinical Practice Recommendations, a series of updated recommendations, to help health care providers treat people with diabetes using the most current research available.
Women who regularly take aspirin seem to be at lower risk of the most common type of breast cancer than those who do not take aspirin, report researchers from Columbia University's Mailman School of Public Health and College of Physicians & Surgeons, Weill Cornell Medical College , and New York-Presbyterian Hospital.
Women who regularly take aspirin seem to be at lower risk of the most common type of breast cancer than those who do not take aspirin, report researchers from Columbia University’s Mailman School of Public Health and College of Physicians & Surgeons, Weill Cornell Medical College, and NewYork-Presbyterian Hospital.
In new studies presented today at Digestive Disease Week in New Orleans, scientists report that women’s preferences for a female physician may delay or prevent proper colorectal screenings due to a lack of females in the field and diabetes may be a significant risk factor for development of colon cancer.
Enteric-coated aspirin is less potent than plain aspirin, which may make it less effective in preventing heart disease, according to a preliminary small study presented today at the American Heart Association’s 5th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology.
Academic hospitals are more likely than community or Veteran’s Administration (VA) hospitals to follow national guidelines for treating patients at risk for blood clots with aspirin or warfarin.
Computer prescribing systems in UK general practices are endangering patients’ lives by failing to pick up on some hazardous drug combinations, say researchers in this week’s British Medical Journal.
New figures raise public fears of a mumps epidemic by showing there were 370 confirmed cases of mumps in the first four months of 2001. This figure is almost an 800% increase on the total of recorded mumps cases for the whole of 2003.
MedImmune, Inc. has announced clinical data showing that a live, attenuated intranasal influenza vaccine (LAIV) may help induce broader immunity in children against drifted influenza strains when compared to the traditional flu shot (TIV).
The study published in this month's edition of the international journal Stroke is the first to provide evidence that blood vessels elsewhere in the body, apart from the brain, in CADASIL sufferers are abnormal in over-constricting in response to the hormone Angiotensin II.
Women who have migraines with aura have a more than 50 percent increased risk of total stroke and 70 percent increase of ischemic stroke compared to those without migraines, according to research that will be presented at the American Academy of Neurology 56th Annual Meeting
In 1970, Mulva Pearson, MD, then 10 years old, left her home country of Jamaica with just the clothes on her back – not even a suitcase. Her destination: the United States, where her mother had been living in search of a better job and better life for her family.
Popping an aspirin the night before you are due to have surgery on neck arteries could help prevent a dangerous complication, a team of researchers at the University of Leicester has discovered.
Fox Chase Cancer Center scientists have identified how an enzyme called COX-2 may promote the development of ovarian tumors, adding further insight into the mechanism of COX-2 inhibitors and the prevention of this highly lethal disease. The data was presented today at the 95th Annual Meeting of the American Association for Cancer Research in Orlando, Fla.
An anti-blood clotting drink has been developed by an up-and-coming biotechnology business based at the University of Liverpool’s Business Incubator, MerseyBIO.
Provexis, a medical food company, is in the final stages of its large-scale trial on the new orange juice drink that has been shown to lower the chance of blood clots and thereby reduce risk of heart attack, stroke and the development of deep vein thrombosis.